N-(2,5-Dimethylphenyl)hydrazinecarbothioamide

Catalog No.: 
ACLPAL025
CAS No.: 
64374-53-4
Molecular Formula: 
C9H13N3S
Molecular Weight: 
195.29
N-(2,5-Dimethylphenyl)hydrazinecarbothioamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$72.00InquiryInquiry
250mg95%$137.00InquiryInquiry
1g95%$348.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(2,5-Dimethylphenyl)hydrazinecarbothioamide
IUPAC NameN-(2,5-dimethylphenyl)hydrazinecarbothioamide
MDL No.MFCD00041280
Molecular FormulaC9H13N3S
Molecular Weight195.29
SMILESNNC(NC1=CC(C)=CC=C1C)=S
InChI KeyGYBFXILIVLNLMM-UHFFFAOYSA-N
Synonym1-amino-3-(2,5-dimethylphenyl)thiourea;3-amino-1-(2,5-dimethylphenyl)thiourea;Hydrazinecarbothioamide, N-(2,5-dimethylphenyl)-
CAS No.64374-53-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H312-H332
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P330-P363-P501

Synthetic Route by SureRoute

1. ACLPAL025 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPUHJ375 route compound structure diagram
    ACPUHJ37519241-15-7In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLPAL025 route product structure diagram
    ACLPAL02564374-53-4
Inquiry

2. ACLPAL025 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACDRSM912 route compound structure diagram
    ACDRSM91251786-53-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLPAL025 route product structure diagram
    ACLPAL02564374-53-4
Inquiry

3. ACLPAL025 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLPAL025 route product structure diagram
    ACLPAL02564374-53-4
Inquiry

Comments (0)